Monthly Archives: October 2014

Earning It

“They make money the old fashioned way. They earn it.“–Houseman, J.,    Barney, S.  1979 The news that AbbVie is pulling out of its arranged marriage with Shire Pharmaceuticals (because tax law revisions are changing the value of inversion deals) … Continue reading

Posted in Big Pharma, BioFollies | Tagged , , , | Leave a comment

Alcobra’s Selective Inattention

Last week, in the October issue of NeuroPerspective, which covered ADHD, we noted the delay in Alcobra’s disclosure of Phase III data for MDX (metadoxine), and stated “ our suspicion is that the analysis of the primary and secondary endpoints … Continue reading

Posted in BioFollies, Biotech | Tagged , , , | 1 Comment

The Flying Dutchman sets course for an IND

<<The Flying Dutchman is a legendary ghost ship that can never make port and is doomed to sail the oceans forever. >>  –Pedia, W. Last November, a disspiriting diaspora of neuro talent from Bristol Myers Squibb  began when BMS decided … Continue reading

Posted in Big Pharma, BioFollies | Tagged , , , | 1 Comment